Marina Chiara Garassino to Compassionate Use Trials
This is a "connection" page, showing publications Marina Chiara Garassino has written about Compassionate Use Trials.
Connection Strength
0.201
-
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program. Eur J Cancer. 2021 05; 149:235-248.
Score: 0.201
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.